Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcranial Magnetic Stimulation | 15 | 2020 | 413 | 1.220 |
Why?
|
| Prefrontal Cortex | 13 | 2020 | 640 | 0.930 |
Why?
|
| Depressive Disorder, Major | 8 | 2011 | 439 | 0.430 |
Why?
|
| Pain | 5 | 2009 | 472 | 0.400 |
Why?
|
| Electroconvulsive Therapy | 3 | 2011 | 402 | 0.380 |
Why?
|
| Schizophrenia | 5 | 2020 | 206 | 0.370 |
Why?
|
| Depressive Disorder | 4 | 2009 | 621 | 0.350 |
Why?
|
| Mood Disorders | 1 | 2011 | 132 | 0.350 |
Why?
|
| Deep Brain Stimulation | 3 | 2011 | 71 | 0.240 |
Why?
|
| Nerve Net | 2 | 2020 | 181 | 0.240 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2020 | 2223 | 0.230 |
Why?
|
| Vagus Nerve | 4 | 2007 | 90 | 0.200 |
Why?
|
| Electric Stimulation | 3 | 2008 | 218 | 0.190 |
Why?
|
| Cortical Excitability | 1 | 2020 | 7 | 0.180 |
Why?
|
| Limbic System | 2 | 2011 | 106 | 0.180 |
Why?
|
| Treatment Failure | 2 | 2011 | 216 | 0.170 |
Why?
|
| Triazines | 2 | 2010 | 48 | 0.170 |
Why?
|
| Valproic Acid | 2 | 2010 | 93 | 0.160 |
Why?
|
| Vagus Nerve Stimulation | 2 | 2011 | 61 | 0.160 |
Why?
|
| Psychiatric Status Rating Scales | 6 | 2011 | 782 | 0.150 |
Why?
|
| Phenanthridines | 2 | 2007 | 8 | 0.150 |
Why?
|
| Cerebral Cortex | 2 | 2011 | 415 | 0.150 |
Why?
|
| Pain Measurement | 5 | 2009 | 328 | 0.140 |
Why?
|
| Functional Laterality | 5 | 2010 | 240 | 0.140 |
Why?
|
| Dopamine Agonists | 2 | 2007 | 68 | 0.140 |
Why?
|
| Receptors, Dopamine D1 | 2 | 2007 | 87 | 0.140 |
Why?
|
| Treatment Outcome | 9 | 2011 | 7029 | 0.140 |
Why?
|
| Adult | 20 | 2020 | 21403 | 0.130 |
Why?
|
| Pain Threshold | 2 | 2006 | 55 | 0.130 |
Why?
|
| Middle Aged | 18 | 2020 | 21147 | 0.120 |
Why?
|
| Double-Blind Method | 5 | 2010 | 1738 | 0.120 |
Why?
|
| Motor Cortex | 2 | 2020 | 158 | 0.110 |
Why?
|
| Humans | 26 | 2020 | 68618 | 0.110 |
Why?
|
| Male | 21 | 2020 | 37321 | 0.100 |
Why?
|
| Antidepressive Agents | 2 | 2011 | 216 | 0.100 |
Why?
|
| Fibromyalgia | 1 | 2011 | 29 | 0.100 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 1 | 2011 | 29 | 0.100 |
Why?
|
| Sensation | 2 | 2009 | 49 | 0.100 |
Why?
|
| Bipolar Disorder | 2 | 2004 | 307 | 0.090 |
Why?
|
| Pain Management | 3 | 2007 | 186 | 0.090 |
Why?
|
| Anticonvulsants | 2 | 2010 | 223 | 0.090 |
Why?
|
| Time Factors | 5 | 2011 | 4655 | 0.090 |
Why?
|
| Affect | 2 | 2009 | 218 | 0.090 |
Why?
|
| Chronic Pain | 1 | 2011 | 110 | 0.090 |
Why?
|
| Brain Mapping | 4 | 2020 | 532 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2009 | 689 | 0.080 |
Why?
|
| Central Nervous System Agents | 1 | 2009 | 37 | 0.080 |
Why?
|
| Pilot Projects | 6 | 2011 | 1342 | 0.080 |
Why?
|
| Dominance, Cerebral | 2 | 2010 | 65 | 0.080 |
Why?
|
| Perception | 1 | 2009 | 189 | 0.080 |
Why?
|
| Female | 17 | 2020 | 38074 | 0.080 |
Why?
|
| Oxygen | 2 | 2007 | 386 | 0.080 |
Why?
|
| Schizophrenic Psychology | 1 | 2007 | 53 | 0.080 |
Why?
|
| Placebos | 1 | 2008 | 195 | 0.070 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2007 | 40 | 0.070 |
Why?
|
| Frontal Lobe | 1 | 2007 | 156 | 0.070 |
Why?
|
| Safety | 1 | 2006 | 145 | 0.060 |
Why?
|
| Adolescent | 5 | 2011 | 8912 | 0.060 |
Why?
|
| Brain Diseases | 1 | 2006 | 78 | 0.060 |
Why?
|
| Anxiety Disorders | 1 | 2008 | 426 | 0.060 |
Why?
|
| Antipsychotic Agents | 1 | 2007 | 247 | 0.060 |
Why?
|
| Electric Stimulation Therapy | 1 | 2006 | 147 | 0.060 |
Why?
|
| Cognition Disorders | 1 | 2007 | 342 | 0.060 |
Why?
|
| Skin | 1 | 2008 | 451 | 0.060 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2004 | 84 | 0.060 |
Why?
|
| Young Adult | 6 | 2011 | 5717 | 0.060 |
Why?
|
| Magnetics | 1 | 2004 | 52 | 0.060 |
Why?
|
| Depression | 2 | 2011 | 943 | 0.060 |
Why?
|
| Surveys and Questionnaires | 2 | 2009 | 2800 | 0.050 |
Why?
|
| Neuropsychological Tests | 3 | 2010 | 517 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2007 | 659 | 0.050 |
Why?
|
| Aged | 7 | 2011 | 14862 | 0.050 |
Why?
|
| Evoked Potentials, Motor | 2 | 2010 | 63 | 0.040 |
Why?
|
| Injections, Subcutaneous | 2 | 2007 | 87 | 0.040 |
Why?
|
| Cross-Over Studies | 2 | 2007 | 260 | 0.030 |
Why?
|
| Atrophy | 2 | 2007 | 112 | 0.030 |
Why?
|
| Risk Factors | 1 | 2006 | 5731 | 0.030 |
Why?
|
| Regional Blood Flow | 2 | 2007 | 168 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2009 | 1040 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2008 | 951 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 1745 | 0.030 |
Why?
|
| Brain | 3 | 2008 | 2176 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 1851 | 0.030 |
Why?
|
| Medical Records | 1 | 2011 | 121 | 0.020 |
Why?
|
| Anisotropy | 1 | 2011 | 105 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2010 | 3259 | 0.020 |
Why?
|
| Electrodes | 1 | 2009 | 147 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2009 | 131 | 0.020 |
Why?
|
| Electromyography | 1 | 2009 | 184 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2010 | 333 | 0.020 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2008 | 88 | 0.020 |
Why?
|
| Panic Disorder | 1 | 2008 | 121 | 0.020 |
Why?
|
| Linear Models | 1 | 2009 | 521 | 0.020 |
Why?
|
| Lidocaine | 1 | 2006 | 36 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2006 | 111 | 0.020 |
Why?
|
| Memory, Short-Term | 1 | 2007 | 79 | 0.020 |
Why?
|
| Epinephrine | 1 | 2006 | 103 | 0.020 |
Why?
|
| Anesthetics, Local | 1 | 2006 | 83 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2007 | 737 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2007 | 296 | 0.020 |
Why?
|
| Motor Activity | 1 | 2009 | 621 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 649 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2005 | 152 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 848 | 0.010 |
Why?
|
| Contrast Media | 1 | 2007 | 595 | 0.010 |
Why?
|
| Long-Term Care | 1 | 2004 | 53 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2007 | 1553 | 0.010 |
Why?
|
| Skull | 1 | 2004 | 63 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 249 | 0.010 |
Why?
|
| Acute Disease | 1 | 2005 | 658 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2007 | 931 | 0.010 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2004 | 257 | 0.010 |
Why?
|
| Affective Symptoms | 1 | 2003 | 50 | 0.010 |
Why?
|
| Electromagnetic Fields | 1 | 2003 | 66 | 0.010 |
Why?
|
| Motor Skills | 1 | 2003 | 88 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2004 | 291 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 4848 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2005 | 1330 | 0.010 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2008 | 1506 | 0.010 |
Why?
|